Burosumab-twza Subcutaneous and Divalproex
Determining the interaction of Burosumab-twza Subcutaneous and Divalproex and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Divalproex Capsules
- Burosumab-twza Subcutaneous-Divalproex Delayed Release
- Burosumab-twza Subcutaneous-Divalproex Delayed Release Tablets
- Burosumab-twza Subcutaneous-Divalproex Extended Release
- Burosumab-twza Subcutaneous-Divalproex Long-Acting Tablets
- Burosumab-twza Subcutaneous-Divalproex sodium
- Divalproex-Buspar
- Divalproex-Buspar Dividose
- Divalproex-Buspirone
- Divalproex-Buspirone Hydrochloride
- Divalproex-Busulfan
- Divalproex-Busulfan Concentrate Injection